Plain-English translation of NCT07556224 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research compares two treatment approaches for ankylosing spondylitis, a condition that causes inflammation and stiffness in the spine. Some participants will receive integrated traditional Chinese and Western medicine together, while others will receive only standard Western medicine. The study will follow nearly 800 people for six months to see which approach helps patients move better and feel better.
Ankylosing spondylitis can be very limiting, and current Western medicine alone may not work well enough for everyone. Researchers want to know whether adding traditional Chinese medicine to standard treatment might help more patients improve their function and live better lives.
You likely qualify if…
You likely don't qualify if…
You will be assigned to receive either combined traditional Chinese and Western medicine or Western medicine alone. Over six months, you'll have follow-up appointments where doctors will check your function, pain, and overall health. The study will track how well you improve and how well you can move and do daily activities.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China
Sponsor
China-Japan Friendship Hospital
Collaborators
The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine, Guangxi Ruikang Hospital
Enrollment target
~790 participants
Started
January 2026
Primary completion
December 2027
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jiaqi Liu
China-Japan Friendship Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.